CIDARA THERAPEUTICS, INC. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
CIDARA THERAPEUTICS, INC. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$29.95 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2019-08-08
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-06-30 was -$12.81M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-03-31 was -$17.15M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-06-30 was -$15.53M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-03-31 was -$14.72M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2017 was -$49.91M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$39.77M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$25.96M.
- CIDARA THERAPEUTICS, INC. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was -$7.71M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2019-06-30 | -$12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$29.95M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | -$17.15M 10-Q · filed 2019-05-09 | |||
| 2018-06-30 | -$15.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$30.25M 10-Q · filed 2019-08-08 | -$39.75M derived: sum of 3 quarters · filed 2019-08-08 | -$53.61M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$14.72M 10-Q · filed 2019-05-09 | -$24.21M derived: sum of 2 quarters · filed 2019-05-09 | -$38.08M derived: sum of 3 quarters · filed 2019-05-09 | -$50.11M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$23.36M derived: sum of 2 quarters · filed 2018-02-27 | -$35.39M derived: sum of 3 quarters · filed 2018-08-09 | -$49.91M 10-K · filed 2018-02-27 |
| 2017-09-30 | -$13.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$25.90M derived: sum of 2 quarters · filed 2018-08-09 | -$40.42M 10-Q · filed 2017-11-08 | -$52.14M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-06-30 | -$12.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$26.55M 10-Q · filed 2018-08-09 | -$38.28M derived: sum of 3 quarters · filed 2018-08-09 | -$45.96M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$14.52M 10-Q · filed 2018-05-10 | -$26.24M derived: sum of 2 quarters · filed 2018-05-10 | -$33.93M derived: sum of 3 quarters · filed 2018-05-10 | -$43.40M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | -$11.73M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$19.41M derived: sum of 2 quarters · filed 2018-02-27 | -$28.89M derived: sum of 3 quarters · filed 2018-02-27 | -$39.77M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$7.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$17.16M derived: sum of 2 quarters · filed 2017-11-08 | -$28.05M 10-Q · filed 2017-11-08 | -$34.78M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$9.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$20.36M 10-Q · filed 2017-08-09 | -$27.10M derived: sum of 3 quarters · filed 2018-02-27 | -$34.40M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$10.89M 10-Q · filed 2017-05-10 | -$17.62M derived: sum of 2 quarters · filed 2018-02-27 | -$24.93M derived: sum of 3 quarters · filed 2018-02-27 | -$30.79M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$14.04M derived: sum of 2 quarters · filed 2018-02-27 | -$19.91M derived: sum of 3 quarters · filed 2018-02-27 | -$25.96M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$7.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$13.17M derived: sum of 2 quarters · filed 2016-11-10 | -$19.22M 10-Q · filed 2016-11-10 | -$22.39M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | -$5.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$11.92M 10-Q · filed 2016-08-11 | -$15.09M derived: sum of 3 quarters · filed 2017-03-15 | -$18.31M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | -$6.05M 10-Q · filed 2016-05-12 | -$9.22M derived: sum of 2 quarters · filed 2017-03-15 | -$12.45M derived: sum of 3 quarters · filed 2017-03-15 | -$13.35M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | -$3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$6.40M derived: sum of 2 quarters · filed 2017-03-15 | -$7.30M derived: sum of 3 quarters · filed 2017-03-15 | -$7.71M 10-K · filed 2017-03-15 |
| 2014-09-30 | -$3.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$4.13M derived: sum of 2 quarters · filed 2015-11-16 | -$4.54M 10-Q · filed 2015-11-16 | |
| 2014-06-30 | -$904.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$1.31M 10-Q · filed 2015-08-11 | ||
| 2014-03-31 | -$410.00K 10-Q · filed 2015-05-21 | |||
| 2013-12-31 | -$1.05M 10-K · filed 2016-03-18 |